Baxter International Inc. (BAX)
Automate Your Wheel Strategy on BAX
With Tiblio's Option Bot, you can configure your own wheel strategy including BAX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol BAX
- Rev/Share 21.2222
- Book/Share 14.2164
- PB 1.6406
- Debt/Equity 1.3286
- CurrentRatio 2.2964
- ROIC -0.0012
- MktCap 12023869038.0
- FreeCF/Share 0.6491
- PFCF 36.1077
- PE -77.4795
- Debt/Assets 0.4621
- DivYield 0.029
- ROE -0.0212
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 3
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | BAX | Stifel | Buy | Hold | -- | $25 | Aug. 4, 2025 |
| Downgrade | BAX | Goldman | Buy | Neutral | -- | $25 | Aug. 1, 2025 |
| Resumed | BAX | Goldman | -- | Buy | -- | $42 | Feb. 26, 2025 |
| Upgrade | BAX | Argus | Hold | Buy | -- | -- | Feb. 24, 2025 |
| Resumed | BAX | Barclays | -- | Overweight | -- | $39 | Feb. 20, 2025 |
News
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit
Published: October 22, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 22, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has already been filed.
Read More
BAX INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 21, 2025 by: Business Wire
Sentiment: Neutral
SAN DIEGO--(BUSINESS WIRE)--The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, both dates inclusive (the “Class Period”), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W. v. Baxter International, Inc., No. 25-cv-12672 (N.D. Ill.), the Baxter.
Read More
BAX INVESTOR ALERT: Baxter International Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 20, 2025 by: PRNewsWire
Sentiment: Neutral
SAN DIEGO , Oct. 20, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025, inclusive (the "Class Period"), have until December 15, 2025 to seek appointment as lead plaintiff of the Baxter class action lawsuit. Captioned Electrical Workers Pension Fund, Local 103, I.B.E.W.
Read More
BAX CLASS ACTION LAWSUIT: Baxter International Inc. Shipping Pauses Trigger Securities Fraud Class Action after Stock Plummets 22% -- Investors Urged to Contact BFA Law
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Baxter International Inc. (NYSE: BAX) and certain of the Company's senior executives for securities fraud after significant stock drop resulting from the potential violations of the federal securities laws. If you invested in Baxter, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/baxter-international-inc-class-action.
Read More
BAX Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Filed Against Baxter International, Inc.
Published: October 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
SAN DIEGO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Baxter International, Inc. (NYSE: BAX) common stock between February 23, 2022 and July 30, 2025. Baxter is a global company that develops, manufactures, and markets medical products used in hospitals and other healthcare facilities.
Read More
Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX
Published: October 20, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)--Baxter International Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – BAX.
Read More
BAX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Published: October 20, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , Oct. 20, 2025 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Baxter International, Inc. ("Baxter" or "the Company") (NYSE: BAX) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Baxter securities between February 23, 2023 and July 30, 2025, both dates inclusive (the "Class Period").
Read More
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
Published: October 17, 2025 by: Business Wire
Sentiment: Neutral
NEW YORK--(BUSINESS WIRE)---- $BAX #BAX--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Baxter International Inc. (“Baxter” or the “Company”) (NYSE: BAX) and reminds investors of the December 15, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The.
Read More
BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm
Published: October 17, 2025 by: Business Wire
Sentiment: Neutral
LOS ANGELES--(BUSINESS WIRE)---- $BAX--BAX Investors Have Opportunity to Lead Baxter International Inc. Securities Fraud Lawsuit with the Schall Law Firm.
Read More
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Baxter International, Inc. (BAX)
Published: October 17, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of Illinois on behalf of all persons or entities who purchased or otherwise acquired Baxter International, Inc. (“Baxter” or the “Company”) (NYSE: BAX) securities between February 23, 2022 and July 30, 2025, inclusive (the “Class Period”).
Read More
Baxter Stock Slips Despite Latest Launch to Boost Patient Monitoring
Published: September 18, 2025 by: Zacks Investment Research
Sentiment: Positive
BAX launches FDA-cleared Connex 360 monitor, aiming to boost frontline care and streamline patient monitoring.
Read More
Is Now The Time To Buy Baxter Stock?
Published: August 26, 2025 by: Forbes
Sentiment: Negative
Baxter stock (NYSE: BAX), a healthcare company, has seen its stock decline by 14% over the past month. This drop followed a disappointing earnings report where the company also reduced its full-year guidance, partly due to Hurricane Helene impacting one of its manufacturing facilities.
Read More
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
Published: August 01, 2025 by: Benzinga
Sentiment: Positive
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Read More
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative
Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
Read More
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Negative
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Read More
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
Published: July 31, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair & Interim CEO Heather Knight - Executive Vice President & COO Joel T. Grade - Executive VP & CFO Conference Call Participants David Harrison Roman - Goldman Sachs Group, Inc., Research Division Lawrence H.
Read More
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Published: July 31, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
Published: July 31, 2025 by: Reuters
Sentiment: Negative
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing facility and reduced demand for IV solutions.
Read More
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
Published: July 30, 2025 by: Zacks Investment Research
Sentiment: Positive
Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended June 2025.
Read More
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
Published: July 28, 2025 by: Zacks Investment Research
Sentiment: Positive
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Read More
Medical Equipment Maker Baxter International Names New CEO
Published: July 07, 2025 by: Investopedia
Sentiment: Neutral
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Read More
Mountain Heating and Cooling Transforms Historic Baxter Hotel with Innovative Mitsubishi Heat Pump Installation
Published: June 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Bozeman, June 11, 2025 (GLOBE NEWSWIRE) -- Bozeman, Montana - Mountain Heating and Cooling recently shared details about their Mitsubishi Heat Pump Installation at the Historic Baxter Hotel in Bozeman Montana . The hotel needed a way to cool its event space while maintaining its historical charm.
Read More
BAX Stock May Rise Following the Launch of FDA-Approved Hemopatch Pad
Published: May 21, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter launches Hemopatch Sealing Hemostat, an FDA-approved collagen pad designed for effective hemostasis and sealing in both open and minimally invasive surgeries.
Read More
4 Goldman Sachs Conviction List Top Picks Are Blue Chip Dividend Stock Royalty
Published: May 16, 2025 by: 24/7 Wall Street
Sentiment: Positive
The artificial intelligence rally over the past two and a half years, led by the so-called Magnificent 7, was remarkable if you owned those stocks.
Read More
The 'Goldilocks' Case For Baxter International
Published: May 08, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International's stock has been challenging to own for the past decade, initially due to high valuations and later due to execution concerns and an ugly acquisition. During the pandemic, health care stocks, including Baxter, underperformed expectations, with BAX peaking in April 2020 before declining. But the divestiture of the kidney care business will help the balance sheet, and management is optimistic toward 2025 performance.
Read More
Baxter International Inc. (BAX) Q1 2025 Earnings Call Transcript
Published: May 01, 2025 by: Seeking Alpha
Sentiment: Neutral
Baxter International Inc. (NYSE:BAX ) Q1 2025 Earnings Conference Call May 1, 2025 8:30 AM ET Company Participants Clare Trachtman - Senior Vice President and Chief Investor Relations Officer Brent Shafer - Chairman and Interim Chief Executive Officer Heather Knight - Chief Operating Officer Joel Grade - Executive Vice President and Chief Financial Officer Conference Call Participants Joanne Wuensch - Citi David Roman - Goldman Sachs Travis Steed - BofA Securities Vijay Kumar - Evercore ISI Robbie Marcus - JPMorgan Larry Biegelsen - Wells Pito Chickering - Deutsche Bank Danielle Antalffy - UBS Operator Good morning, ladies and gentlemen, and …
Read More
BAX Stock Gains Following Q1 Earnings Beat Estimates, Revenues Up Y/Y
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Baxter reports better-than-expected first-quarter results. However, the company's gross margin contracts.
Read More
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Neutral
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Read More
Baxter (BAX) Reports Q1 Earnings: What Key Metrics Have to Say
Published: May 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Although the revenue and EPS for Baxter (BAX) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Read More
MedTech Stocks' Earnings to Watch on May 1: BDX, CAH, BAX, DXCM & SYK
Published: April 30, 2025 by: Zacks Investment Research
Sentiment: Positive
This earnings season so far has reflected a continued recovery in sales for companies within the Medical sector. Earnings have increased year over year, albeit at a slower pace than revenues.
Read More
About Baxter International Inc. (BAX)
- IPO Date 1981-10-27
- Website https://www.baxter.com
- Industry Medical - Instruments & Supplies
- CEO David Brent Shafer
- Employees 38000